GV returned to help heart disease drug developer Tenaya boost its overall funding to approximately $248m.

RTW Investments has a series C for the UT Southwestern and Gladstone Institutes spinout, which will progress its lead asset into the clinic.

Siemens’ Next47 subsidiary has returned to back the unmanned aerial vehicle technology producer’s latest round, valuing it above $1bn.

Salesforce Ventures helped the professional coaching services provider push its valuation past $1.7bn in its series D round.

New and returning investors participated in the Kaplan-backed educational content provider’s latest round, which boosted its overall funding to $170m.

GC and its GC LabCell subsidiary both contributed to a round that will help advance the cancer immunotherapy developer's NK cell drug pipeline.

AI chip developer Horizon Robotics raised a round backed by several automotive manufacturers, taking its overall funding to $900m in the past two months.

The Jinlong Group-backed biologic drug developer’s latest round pushed its overall funding from the past 12 months to approximately $387m.

The Baidu, Geely and SIG-backed in-car technology developer hiked its valuation to $2bn in a series A-plus round led by China Venture Capital Fund.

Microsoft unit M12 backed the healthcare data software provider in a round that valued the latter at $1.3bn, pushing its overall funding past $225m.